Ajay Kottapalli, MD
Internal Medicine · Gallipolis, OHNPI 1174560148
Payments from drug & device makers
Across 45 payments — averaging $14.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$186
- AstraZeneca$66
- AbbVie$49
- Novo Nordisk$48
- Novartis$36
- Otsuka America Pharmaceutical, Inc.$32
- plus $228 from 14 others
What the payments were for
- Food & beverage$644100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 13 | $186 |
| AstraZeneca | 5 | $66 |
| AbbVie | 2 | $49 |
| Novo Nordisk | 3 | $48 |
| Novartis | 3 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Mylan Specialty L.p. | 2 | $27 |
| GSK | 2 | $25 |
| Boehringer Ingelheim | 2 | $24 |
| Bayer | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Xeris Pharmaceuticals, Inc. | 1 | $12 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
| Amarin Pharma, Inc. | 1 | $11 |
| UCB, Inc. | 1 | $11 |
How this compares
$644 in reported general payments places this provider in the 65th percentile of 4,428 internal medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 454 | $6,616 |
| Prednisone | 285 | $1,452 |
| PaxlovidNirmatrelvir/Ritonavir | 36 | $1,429 |
| Ondansetron Hcl | 49 | $1,190 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 21 | $1,031 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 66 | $1,014 |
| Diclofenac Sodium | 36 | $684 |
| Doxycycline Hyclate | 65 | $539 |
| Mupirocin | 73 | $503 |
| Oseltamivir Phosphate | 17 | $364 |
| ErythromycinErythromycin Base | 23 | $362 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 42 | $324 |
| Mometasone Furoate | 11 | $217 |
| ValacyclovirValacyclovir Hcl | 11 | $206 |
| Ibuprofen | 82 | $182 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Gallipolis
- Antoinette PragalosCincinnati$27.8M
- Steven FolkerthBeavercreek$9.1M
- Charles EgerCincinnati$8.7M
- Vadim KoshkinCleveland$6.1M
- Nizar DaboulMaumee$4.7M
- Douglas LoganCincinnati$4.7M
- Seref BornovaliLoveland$4.4M
- Yevgeniy BukhmanCanton$3.7M
- Leela VrishabhendraCincinnati$3.4M
- Narinder SainiSpringfield$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.